SUBSCRIBE
SUBSCRIBE

Dynavax Technologies

NEWS
What You Missed: Nippon Fine Chemical Formed Human Barricade to Stop FDA Employee
Drug Development
FDA Panel Votes to Recommend Dynavax’s Hepatitis B Vaccine; Hepsilav Can Compete With GlaxoSmithKline’s Engerix-B
July 31, 2017
 · 
2 min read
Bay Area's Dynavax Quietly Shops Around Its Almost-Approved Hep B Vaccine
Drug Development
Death Count Rises for Patients on Dynavax’s Hep B Vaccine But Overall Rate Was Low, Says the FDA
July 26, 2017
 · 
2 min read
Bay Area's Dynavax Quietly Shops Around Its Almost-Approved Hep B Vaccine
Job Trends
Bay Area’s Dynavax Shifts Focus to Immune-Oncology, Cuts 40% of Staff
March 13, 2017
 · 
3 min read
Biotech Bay
Dynavax In 2017: Hero Or Zero?
January 19, 2017
 · 
1 min read
Bay Area's Depomed Craters as New CEO, Directors are Named in Deal with Activist Investor
Job Trends
Bay Area’s Dynavax Slashes Global Workforce by 38% in Restructuring
January 5, 2017
 · 
3 min read
Antares Pharma Implodes After FDA Responds to Its Xyosted NDA
FDA
Bay Area’s Dynavax Plunges After the FDA Spurns HEPLISAV-B Again
November 14, 2016
 · 
2 min read
Biotech Bay
Bay Area’s Dynavax Could Need a Plan B if Heplisav-B is Rejected in December
October 17, 2016
 · 
1 min read
Top 5 Bay Area Biomed Hot Spots
Job Trends
Top 5 Bay Area Biomed Hot Spots
June 20, 2016
 · 
5 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Biotech Bay
In a Volatile Biotech Market, Here are 3 Stocks To Consider
April 12, 2016
 · 
3 min read
Load More
JOBS
IN THE PRESS
Press Releases
Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline
December 24, 2025
 · 
13 min read
Press Releases
Sanofi to Acquire Dynavax, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline
December 24, 2025
 · 
11 min read
Press Releases
Dynavax to Participate at the 8th Annual Evercore Healthcare Conference
November 20, 2025
 · 
1 min read
Press Releases
Dynavax Enters Exclusive License Agreement for Vaxart’s Novel Oral COVID-19 Vaccine Program
November 5, 2025
 · 
12 min read
Press Releases
Dynavax to Report Third Quarter 2025 Financial Results and Host Conference Call on November 5, 2025
October 22, 2025
 · 
1 min read
Press Releases
Dynavax Presents Positive Topline Data from Part 1 of Phase 1/2 Trial for Shingles Vaccine Candidate at IDWeek 2025 and Announces Initiation of Part 2 of Trial
October 21, 2025
 · 
6 min read
Press Releases
Dynavax to Participate in the 2025 Wells Fargo Healthcare Conference
August 28, 2025
 · 
1 min read
Press Releases
Dynavax Announces Positive Topline Phase 1/2 Results Supporting Potential Best-in-Class Shingles Vaccine Profile
August 22, 2025
 · 
9 min read
Press Releases
Dynavax Reports Second Quarter 2025 Financial Results
August 8, 2025
 · 
17 min read
Press Releases
Dynavax to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025
July 29, 2025
 · 
1 min read
Load More